NCT03520660 2026-04-14
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Phase 4 Active not recruiting
Clinical Trials
102 trialsNCT07059494 2026-03-23
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Icahn School of Medicine at Mount Sinai
Phase 4 Recruiting
NCT04288323 2026-02-12
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
University of California, San Diego
Phase 4 Completed
NCT02081755 2026-01-27
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Baylor Research Institute
Phase 4 Enrolling by invitation
NCT04373564 2026-01-22
ODYSSEY
Guerbet
Phase 4 Recruiting
NCT07358975 2026-01-22
Prediction of Complications in Hepatic Tumors
Rigshospitalet, Denmark
Phase 4 Not yet recruiting
NCT06786429 2026-01-21
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Eunice Dube
Phase 4 Not yet recruiting
NCT07315022 2026-01-02
Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University
Phase 4 Completed
NCT06717919 2025-12-16
HOPE4Cancer
Clarunis - Universitäres Bauchzentrum Basel
Phase 4 Recruiting
NCT03963206 2025-12-01
CLERANCE
Hospices Civils de Lyon
Phase 4 Completed
NCT06084234 2025-11-26
TRACER
University of Texas Southwestern Medical Center
Phase 4 Recruiting
NCT07160361 2025-09-16
Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB
Second Affiliated Hospital of Xi'an Jiaotong University
Phase 4 Not yet recruiting
NCT07150624 2025-09-02
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Anhui Provincial Hospital
Phase 4 Recruiting
NCT07132515 2025-08-20
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Mansoura University
Phase 4 Recruiting
NCT05178303 2025-05-16
SB-1121
Trieu, Nguyen Thi, M.D.
Phase 4 Completed
NCT06923176 2025-04-11
BRCSRRRHCCART
Beijing Ditan Hospital
Phase 4 Not yet recruiting
NCT06594744 2025-02-13
P-HCC-CVL
Taipei Veterans General Hospital, Taiwan
Phase 4 Recruiting
NCT05848947 2025-01-29
MAApping
Sirtex Medical
Phase 4 Completed
NCT03024684 2024-11-12
SHOT
Chiayi Christian Hospital
Phase 4 Active not recruiting
NCT06464380 2024-09-23
Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma
Ain Shams University
Phase 4 Not yet recruiting
NCT04562428 2024-05-16
The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial
China Medical University Hospital
Phase 4 Completed
NCT06398028 2024-05-03
The Preoperative Administration of ICG Improves Tumor Detection in Patients Undergoing Minimally Invasive Hepatic Resection Guided by Conventional Intraoperative Ultrasound.
Hospital Universitari Vall d'Hebron Research Institute
Phase 4 Recruiting
NCT06311916 2024-03-15
Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.
Tongji Hospital
Phase 4 Not yet recruiting
NCT06041425 2024-02-28
The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE
The First Affiliated Hospital with Nanjing Medical University
Phase 4 Completed
NCT04297254 2023-11-15
A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC
Eisai Inc.
Phase 4 Completed
NCT04569799 2023-11-02
TACE
Milton S. Hershey Medical Center
Phase 4 Completed
NCT06003673 2023-10-24
A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC
First Affiliated Hospital of Fujian Medical University
Phase 4 Unknown
NCT02174575 2023-05-03
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
Tokyo Medical and Dental University
Phase 4 Withdrawn
NCT04653818 2023-04-04
RCT
Alexandria University
Phase 4 Completed
NCT05670561 2023-03-29
Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma
The Second Affiliated Hospital of Chongqing Medical University
Phase 4 Unknown
NCT05416073 2023-02-24
TACE-HAIC
The Second Affiliated Hospital of Chongqing Medical University
Phase 4 Unknown
NCT05185505 2023-02-01
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
The Methodist Hospital Research Institute
Phase 4 Recruiting
NCT05331911 2022-11-30
Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase 4 Recruiting
NCT02224456 2022-02-14
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
GlaxoSmithKline
Phase 4 Completed
NCT05113290 2022-01-27
Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment
First Affiliated Hospital Xi'an Jiaotong University
Phase 4 Unknown
NCT04127396 2021-07-23
Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT
Beijing Ditan Hospital
Phase 4 Unknown
NCT02472249 2021-04-28
Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC
University Health Network, Toronto
Phase 4 Completed
NCT03215355 2021-01-27
Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium
Nova Scotia Health Authority
Phase 4 Withdrawn
NCT03007225 2020-10-22
Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients
Ain Shams University
Phase 4 Completed
NCT01760616 2020-03-06
Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
Qidong Gaitianli Medicines Co., Ltd
Phase 4 Terminated
NCT02504983 2020-02-05
Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma
Chang Gung Memorial Hospital
Phase 4 Unknown
NCT02961998 2019-09-10
Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail
Sun Yat-sen University
Phase 4 Completed
NCT01451658 2019-09-04
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT01970748 2019-08-30
P-HCC
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT03212625 2019-08-22
The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction
Korea University Guro Hospital
Phase 4 Completed
NCT02733809 2019-08-20
Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma
King Saud University
Phase 4 Unknown
NCT01806740 2019-08-08
DCE-MRI
Guerbet
Phase 4 Terminated
NCT04015245 2019-07-10
SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy
Chimei Medical Center
Phase 4 Completed
NCT03996681 2019-06-25
TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma
Suzhou Municipal Hospital
Phase 4 Unknown
NCT01952353 2019-03-07
Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion
Sun Yat-sen University
Phase 4 Completed